Evidence map›Paper›PMID 35434259›Full record

ArticleInternational journal of cardiology. Heart & vasculature2022

Mid-term results of surgical aortic valve replacement with bioprostheses in hemodialysis patients.

Ikuko Shibasaki, Taira Fukuda, Hironaga Ogawa, Go Tsuchiya, Yusuke Takei, Masahiro Seki, Takashi Kato, Yuta Kanazawa, Shunsuke Saito, Toshiyuki Kuwata and 3 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of cardiology. Heart & vasculature, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Ikuko ShibasakiDepartment of Cardiac and Vascular Surgery, Dokkyo Medical University, Tochigi, Japan.
Taira FukudaDepartment of Liberal Arts and Human Development, Kanagawa University of Human Services, Kanagawa 238-8522, Japan.
Hironaga OgawaDepartment of Cardiac and Vascular Surgery, Dokkyo Medical University, Tochigi, Japan.
Go TsuchiyaDepartment of Cardiac and Vascular Surgery, Dokkyo Medical University, Tochigi, Japan.
Yusuke TakeiDepartment of Cardiac and Vascular Surgery, Dokkyo Medical University, Tochigi, Japan.
Masahiro SekiDivision of Cardiovascular Surgery, Gunma Prefectural Cardiovascular Centre, Gunma, Japan.
Takashi KatoDepartment of Cardiovascular Surgery, Maebashi Red Cross Hospital, Gunma, Japan.
Yuta KanazawaDepartment of Cardiac and Vascular Surgery, Dokkyo Medical University, Tochigi, Japan.
Shunsuke SaitoDepartment of Cardiac and Vascular Surgery, Dokkyo Medical University, Tochigi, Japan.
Toshiyuki KuwataDepartment of Cardiovascular Surgery, Maebashi Red Cross Hospital, Gunma, Japan.
Yasuyuki YamadaDivision of Cardiovascular Surgery, Gunma Prefectural Cardiovascular Centre, Gunma, Japan.
Yasuo HaruyamaCenter for Research Collaboration and Support, Dokkyo Medical University School of Medicine, Japan.
Hirotsugu FukudaDepartment of Cardiac and Vascular Surgery, Dokkyo Medical University, Tochigi, Japan.
Dokkyo Medical University · JPGunma Prefectural Cardiovascular Center · JPMaebashi Red Cross Hospital · JPKanagawa University of Human Services · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Limited studies have assessed the factors affecting prognosis in hemodialysis (HD) patients who undergo surgical aortic valve replacement with a bioprostheses (SAVR-BP). This study aimed to evaluate the outcomes of HD patients who had undergone SAVR-BP for aortic stenosis (AS) and identify the risk factors for mortality. Methods: This retrospective study included 57 HD patients who had undergone SAVR-BP for AS between July 2009 and December 2020. Multivariate logistic regression was used to predict factors associated with mid-term outcomes and death or survival. Kaplan - Meier curves were also generated for mid-term survival. Results: The in-hospital mortality rate was 8.8%, and the 5-year mortality rate was 42.1%. The independent predictors of 5-year mortality were preoperative age (hazard ratio [HR], 1.57; 95% confidence interval [CI], 1.175-2.083, p = 0.002), hyperlipidemia (HR, 0.02; 95% CI, 0.002-0.297, p = 0.004), left ventricular diastolic diameter (HR, 1.74; 95% CI, 1.142-2.649, p = 0.010), left ventricular systolic diameter (HR, 0.61; 95% CI, 0.392-0.939, p = 0.025), and Japan SCORE (HR, 1.28; 95% CI, 1.052-1.563, p = 0.014). The postoperative predictors included intensive care unit stay (HR, 1.11; 95% CI, 1.035-1.194, p = 0.004) and albumin level (HR, 0.38; 95% CI, 0.196-0.725, p = 0.003). Conclusions: The 5-year prognosis of HD patients undergoing SAVR may be improved by early diagnosis (before the occurrence of LV hypertrophy/enlargement) and nutritional management with oral intake to alleviate postoperative hypoalbuminemia.

Indexed as

95% CI, confidence intervalAf, atrial fibrillationAortic valve stenosisAPACHE, Acute Physiology and Chronic Health EvaluationAS, aortic stenosisAXA, axillary arteryBioprosthesesCABG, coronary artery bypass graftCPB, cardiopulmonary bypassCP, cold blood cardioplegiaDd, diastolic diameterDs, systolic diameterECMO, extracorporeal membrane oxygenationHD, hemodialysisHemodialysisHF, heart failureHR, hazard ratioIABP, intra-aortic balloon pumpingICU, intensive care unitLOS, low output syndromeLVEF, left ventricle ejection fractionLV, left ventricularMACCE, major adverse cardiovascular and cerebrovascular eventsMI, myocardial infarctionSAPS II, Simple Acute Physiology Score IISAVR-BP, SAVR with bioprosthesesSAVR, surgical aortic valve replacementSD, standard deviationSOFA, Sequential Organ Failure AssessmentSurgical aortic valve replacementTAVR, transcatheter aortic valve replacement

Identifiers

PMID35434259
PMCPMC9011164
OpenAlexW4225688930

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.